20 June 2013
Keywords: poland, place, pharmaceutical, investments, capgemini, report, suggests
Article | 12 July 2004
The entry of US generic drugmaker IVAX onto the Polish market, via itsacquisition of shares in drugmaker Polfa Kutno (Marketletter ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 July 2004
19 June 2013
© 2013 thepharmaletter.com